SUNP remains on track to expand its innovative medicines portfolio through a) product filing with USFDA, b) commercial ...

Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & loss statements.

Sun Pharma Share Price Target 2026: The pharma giant reported a upbeat results for the fourth quarter of FY26, with ...

Sun Pharma's acquisition of Organon as a transformational deal, doubling revenue to USD 12 billion with 30 per cent EBITDA margin, analysts.

In the March quarter, Sun Pharma reported net profit at ₹2,714 crore, as compared to ₹2,150 crore a year ago, up 26.2 per ...

Welcome to the Sun Pharma Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a ...

Stay informed with the Sun Pharma Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of a leading stock. Get the latest details on Sun Pharma, including: Last ...

Sun Pharma shares remained volatile after the pharma giant reported 26.2% surge in net profit on an year-on-year basis.

Sun Pharma’s Q4FY26 numbers missed on margins but not on confidence. Three brokerages stayed bullish as specialty medicines, ...

Track Sun Pharmaceutical Industries share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, ...

Stock continues to show pressure even with a fine tuned operating performance, US sales decline which skew profit losses.

Sun Pharmaceutical to acquire Organon in an $11.75 billion all-cash deal, marking its entry into biosimilars and strengthening its global presence in women’s health and specialty medicines.